Identification of a novel fusion TBL1XR1–PDGFRB in a patient with acute myeloid leukemia harboring the DEK–NUP214 fusion and clinical response to dasatinib

Paulo Vidal CampregherDepartment of Hematology and Clinical Pathology, Research Institute, Hospital Israelita Albert Einstein, São Paulo, Brazil; ;Foundation Medicine, Cambridge, MT; ;Department of Hematology, University of Campinas (Hemocentro - Unicamp), Campinas, São Paulo, Brazil; Correspondence[email protected]

Nathalia da Silva HalleyDepartment of Pediatric, Hospital Israelita Albert Einstein, São Paulo, Brazil;

Gabriela Amaral VieiraDepartment of Hematology and Clinical Pathology, Research Institute, Hospital Israelita Albert Einstein, São Paulo, Brazil;

Juliana Folloni FernandesHematology and Bone Marrow Transplantation Program, Hospital Israelita Albert Einstein, São Paulo, Brazil;

Elvira Deolinda Rodrigues Pereira VellosoHematology Service, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil; ;Cytogenetics Laboratories, Hospital Israelita Albert Einstein, São Paulo, Brazil;

Siraj AliFoundation Medicine, Cambridge, MT;

Tariq MughalTufts University Cancer Center, Boston, MA, USA;

Vincent MillerFoundation Medicine, Cambridge, MT;

Cristovão Luis Pitangueira MangueiraDepartment of Hematology and Clinical Pathology, Research Institute, Hospital Israelita Albert Einstein, São Paulo, Brazil;

Vicente OdoneDepartment of Pediatric Oncology, Hospital Israelita Albert Einstein, São Paulo, Brazil;

Nelson HamerschlakDepartment of Hematology, Hospital Israelita Albert Einstein, São Paulo, Brazil

show all

Identification of a novel fusion TBL1XR1–PDGFRB in a patient with acute myeloid leukemia harboring the DEK–NUP214 fusion and clinical response to dasatinib

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Identification of a novel fusion TBL1XR1–PDGFRB in a patient with acute myeloid leukemia harboring the DEK–NUP214 fusion and clinical response to dasatinib

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date